Your browser doesn't support javascript.
loading
[Evaluation of clinical outcomes of allogeneic hematopoietic stem cell transplantation for relapsed/refractory peripheral T-cell lymphoma with chemoresistance].
Wang, L; Li, N N; Wang, Z; Wu, X X; Dong, Y J; Fu, X R; Liu, Y; Hu, L D; Li, X F; Wang, Y N; Wu, Y M; Ren, H Y; Zhang, M Z; Wang, M H; Li, Y H; Liu, D H; Huang, W R.
Affiliation
  • Wang L; Department of Hematology, the First Medical Center of Chinese PLA General Hospital, Beijing 100853, China.
  • Li NN; Department of Hematology, Fujian Medical University Union Hospital, Fuzhou 350001, China.
  • Wang Z; Department of Hematology, Beijing Friendship Hospital, Hematology Department, Beijing 100050, China.
  • Wu XX; Department of Hematology, the Forth Medical Center of Chinese PLA General hospital, Beijing 100048, China.
  • Dong YJ; Department of Hematology, Peking University First Hospital, Beijing 100034, China.
  • Fu XR; Oncology Department, the First Affiliated Hospital of Zhengzhou University, Zhengzhou 450000, China.
  • Liu Y; Department of Hematology, Xinqiao Hospital, Army Medical University, Chongqing 400037, China.
  • Hu LD; Department of Hematological Stem Cell Transplant, the Fifith Medical Center of Chinese PLA General hospital, Beijing 100071,China.
  • Li XF; Department of Hematology, Fujian Medical University Union Hospital, Fuzhou 350001, China.
  • Wang YN; Department of Hematology, Beijing Friendship Hospital, Hematology Department, Beijing 100050, China.
  • Wu YM; Department of Hematology, the Forth Medical Center of Chinese PLA General hospital, Beijing 100048, China.
  • Ren HY; Department of Hematology, Peking University First Hospital, Beijing 100034, China.
  • Zhang MZ; Oncology Department, the First Affiliated Hospital of Zhengzhou University, Zhengzhou 450000, China.
  • Wang MH; Department of Hematology, Xinqiao Hospital, Army Medical University, Chongqing 400037, China.
  • Li YH; Department of Hematological Stem Cell Transplant, the Fifith Medical Center of Chinese PLA General hospital, Beijing 100071,China.
  • Liu DH; Department of Hematology, the First Medical Center of Chinese PLA General Hospital, Beijing 100853, China.
  • Huang WR; Department of Hematology, the First Medical Center of Chinese PLA General Hospital, Beijing 100853, China.
Zhonghua Yi Xue Za Zhi ; 99(48): 3786-3791, 2019 Dec 24.
Article in Zh | MEDLINE | ID: mdl-31874515
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Lymphoma, T-Cell, Peripheral / Hematopoietic Stem Cell Transplantation / Graft vs Host Disease Type of study: Observational_studies / Risk_factors_studies Limits: Humans Language: Zh Journal: Zhonghua Yi Xue Za Zhi Year: 2019 Document type: Article Affiliation country: China Country of publication: China
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Lymphoma, T-Cell, Peripheral / Hematopoietic Stem Cell Transplantation / Graft vs Host Disease Type of study: Observational_studies / Risk_factors_studies Limits: Humans Language: Zh Journal: Zhonghua Yi Xue Za Zhi Year: 2019 Document type: Article Affiliation country: China Country of publication: China